Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sex Workers | 10 | 2024 | 116 | 3.340 |
Why?
|
| Circumcision, Male | 6 | 2018 | 99 | 1.470 |
Why?
|
| HIV Infections | 18 | 2024 | 5097 | 1.400 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2019 | 256 | 0.990 |
Why?
|
| Adult | 26 | 2024 | 5913 | 0.910 |
Why?
|
| South Africa | 28 | 2024 | 7596 | 0.830 |
Why?
|
| HIV Seropositivity | 2 | 2022 | 265 | 0.820 |
Why?
|
| Funeral Homes | 2 | 2019 | 6 | 0.800 |
Why?
|
| Physical Abuse | 1 | 2022 | 8 | 0.790 |
Why?
|
| Sex Offenses | 1 | 2022 | 29 | 0.780 |
Why?
|
| Substance-Related Disorders | 1 | 2022 | 51 | 0.770 |
Why?
|
| Humans | 33 | 2024 | 14537 | 0.760 |
Why?
|
| Health Personnel | 3 | 2022 | 231 | 0.670 |
Why?
|
| Self Care | 1 | 2019 | 14 | 0.660 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 146 | 0.650 |
Why?
|
| Serologic Tests | 1 | 2019 | 26 | 0.650 |
Why?
|
| Mortuary Practice | 1 | 2019 | 3 | 0.640 |
Why?
|
| Tuberculosis | 5 | 2023 | 543 | 0.630 |
Why?
|
| Cross-Sectional Studies | 9 | 2023 | 1422 | 0.610 |
Why?
|
| Occupational Diseases | 1 | 2019 | 40 | 0.610 |
Why?
|
| Research | 1 | 2019 | 65 | 0.610 |
Why?
|
| Mycobacterium tuberculosis | 4 | 2023 | 329 | 0.610 |
Why?
|
| Mass Screening | 1 | 2019 | 245 | 0.570 |
Why?
|
| Female | 22 | 2024 | 9103 | 0.540 |
Why?
|
| Hypertension | 1 | 2021 | 419 | 0.540 |
Why?
|
| Treatment Refusal | 1 | 2016 | 13 | 0.530 |
Why?
|
| Male | 20 | 2024 | 6754 | 0.510 |
Why?
|
| Tuberculosis, Pulmonary | 3 | 2023 | 324 | 0.460 |
Why?
|
| Contact Tracing | 3 | 2020 | 48 | 0.450 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 262 | 0.450 |
Why?
|
| HIV-1 | 1 | 2022 | 1260 | 0.440 |
Why?
|
| Young Adult | 9 | 2024 | 2498 | 0.420 |
Why?
|
| Intimate Partner Violence | 2 | 2023 | 55 | 0.380 |
Why?
|
| Prevalence | 5 | 2022 | 1192 | 0.370 |
Why?
|
| HIV | 3 | 2023 | 380 | 0.330 |
Why?
|
| Latent Tuberculosis | 2 | 2020 | 45 | 0.290 |
Why?
|
| Middle Aged | 9 | 2024 | 3601 | 0.270 |
Why?
|
| Prospective Studies | 5 | 2024 | 1160 | 0.260 |
Why?
|
| Surgical Instruments | 2 | 2015 | 11 | 0.260 |
Why?
|
| Antitubercular Agents | 2 | 2021 | 322 | 0.250 |
Why?
|
| Morals | 1 | 2024 | 5 | 0.240 |
Why?
|
| Adolescent | 6 | 2022 | 2985 | 0.230 |
Why?
|
| Sputum | 2 | 2023 | 135 | 0.230 |
Why?
|
| Community-Acquired Infections | 1 | 2024 | 102 | 0.220 |
Why?
|
| Global Health | 1 | 2024 | 193 | 0.220 |
Why?
|
| Rape | 1 | 2023 | 10 | 0.210 |
Why?
|
| Tobacco Use Disorder | 1 | 2022 | 7 | 0.210 |
Why?
|
| Cannabis | 1 | 2022 | 10 | 0.210 |
Why?
|
| Caregivers | 1 | 2022 | 76 | 0.200 |
Why?
|
| Pneumococcal Vaccines | 1 | 2024 | 278 | 0.190 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 2021 | 195 | 0.190 |
Why?
|
| Bacterial Load | 1 | 2021 | 32 | 0.190 |
Why?
|
| Mental Health | 2 | 2021 | 91 | 0.190 |
Why?
|
| Employment | 1 | 2021 | 27 | 0.180 |
Why?
|
| Ambulatory Care Facilities | 1 | 2021 | 125 | 0.180 |
Why?
|
| Comorbidity | 1 | 2021 | 188 | 0.180 |
Why?
|
| Homosexuality, Male | 1 | 2021 | 52 | 0.180 |
Why?
|
| Pre-Exposure Prophylaxis | 1 | 2023 | 196 | 0.170 |
Why?
|
| Risk Factors | 5 | 2024 | 1475 | 0.170 |
Why?
|
| Medical Waste Disposal | 1 | 2019 | 3 | 0.170 |
Why?
|
| Safety Management | 1 | 2019 | 4 | 0.170 |
Why?
|
| Aged | 5 | 2024 | 1740 | 0.170 |
Why?
|
| Quality of Life | 1 | 2021 | 177 | 0.170 |
Why?
|
| Patient Readmission | 1 | 2019 | 6 | 0.170 |
Why?
|
| Personal Protective Equipment | 1 | 2019 | 16 | 0.170 |
Why?
|
| Pain | 2 | 2018 | 41 | 0.160 |
Why?
|
| Qualitative Research | 1 | 2021 | 321 | 0.160 |
Why?
|
| Vaping | 1 | 2018 | 2 | 0.160 |
Why?
|
| Hospital Mortality | 1 | 2019 | 95 | 0.160 |
Why?
|
| Public Policy | 1 | 2018 | 24 | 0.160 |
Why?
|
| Feasibility Studies | 1 | 2019 | 101 | 0.160 |
Why?
|
| Research Personnel | 1 | 2019 | 19 | 0.160 |
Why?
|
| Mortality | 1 | 2019 | 104 | 0.150 |
Why?
|
| Attitude to Health | 1 | 2018 | 56 | 0.150 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2018 | 12 | 0.150 |
Why?
|
| Motivation | 1 | 2018 | 59 | 0.150 |
Why?
|
| Surveys and Questionnaires | 2 | 2018 | 563 | 0.150 |
Why?
|
| Depression | 1 | 2018 | 121 | 0.140 |
Why?
|
| Anti-HIV Agents | 2 | 2023 | 1324 | 0.140 |
Why?
|
| Perception | 1 | 2016 | 42 | 0.130 |
Why?
|
| Violence | 3 | 2023 | 68 | 0.130 |
Why?
|
| Health Services Accessibility | 1 | 2018 | 280 | 0.130 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 239 | 0.130 |
Why?
|
| Tuberculin Test | 3 | 2020 | 49 | 0.120 |
Why?
|
| Cost-Benefit Analysis | 3 | 2023 | 253 | 0.110 |
Why?
|
| Isoniazid | 1 | 2014 | 110 | 0.110 |
Why?
|
| Treatment Outcome | 3 | 2021 | 889 | 0.100 |
Why?
|
| Incidence | 2 | 2024 | 685 | 0.090 |
Why?
|
| Sex Work | 2 | 2021 | 39 | 0.090 |
Why?
|
| Pandemics | 2 | 2023 | 296 | 0.090 |
Why?
|
| Communicable Disease Control | 2 | 2023 | 101 | 0.090 |
Why?
|
| Hospitalization | 2 | 2024 | 418 | 0.080 |
Why?
|
| Child | 3 | 2022 | 2242 | 0.080 |
Why?
|
| Retrospective Studies | 2 | 2023 | 799 | 0.080 |
Why?
|
| Pain Measurement | 2 | 2016 | 15 | 0.070 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2024 | 100 | 0.060 |
Why?
|
| Hospitals | 1 | 2023 | 103 | 0.050 |
Why?
|
| Autopsy | 1 | 2023 | 140 | 0.050 |
Why?
|
| Tobacco Smoking | 1 | 2022 | 15 | 0.050 |
Why?
|
| Social Stigma | 1 | 2023 | 80 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2023 | 385 | 0.050 |
Why?
|
| Microscopy | 1 | 2021 | 21 | 0.050 |
Why?
|
| Biomarkers | 1 | 2022 | 327 | 0.050 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2021 | 35 | 0.050 |
Why?
|
| Primary Health Care | 1 | 2023 | 240 | 0.050 |
Why?
|
| Sexual and Gender Minorities | 1 | 2021 | 29 | 0.050 |
Why?
|
| Models, Biological | 1 | 2021 | 77 | 0.040 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 59 | 0.040 |
Why?
|
| Anti-Retroviral Agents | 1 | 2024 | 551 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 370 | 0.040 |
Why?
|
| Standard of Care | 1 | 2019 | 30 | 0.040 |
Why?
|
| Risk | 1 | 2019 | 87 | 0.040 |
Why?
|
| Waste Disposal Facilities | 1 | 2019 | 9 | 0.040 |
Why?
|
| Inpatients | 1 | 2019 | 30 | 0.040 |
Why?
|
| Disease Transmission, Infectious | 1 | 2019 | 39 | 0.040 |
Why?
|
| Wounds and Injuries | 1 | 2019 | 26 | 0.040 |
Why?
|
| Family Characteristics | 1 | 2020 | 135 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2019 | 27 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 2018 | 1 | 0.040 |
Why?
|
| Serbia | 1 | 2018 | 1 | 0.040 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2018 | 1 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 171 | 0.040 |
Why?
|
| Patient Outcome Assessment | 1 | 2018 | 8 | 0.040 |
Why?
|
| Analgesia | 1 | 2018 | 8 | 0.040 |
Why?
|
| Pain Management | 1 | 2018 | 12 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2018 | 54 | 0.040 |
Why?
|
| Logistic Models | 1 | 2018 | 254 | 0.040 |
Why?
|
| Vaccination | 1 | 2019 | 365 | 0.030 |
Why?
|
| Mozambique | 1 | 2016 | 55 | 0.030 |
Why?
|
| Direct Service Costs | 1 | 2015 | 3 | 0.030 |
Why?
|
| Wound Healing | 1 | 2016 | 29 | 0.030 |
Why?
|
| Zambia | 1 | 2016 | 115 | 0.030 |
Why?
|
| Viral Load | 1 | 2019 | 819 | 0.030 |
Why?
|
| Schools | 1 | 2015 | 73 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2015 | 1748 | 0.020 |
Why?
|